Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
life sciences & biomedicine (89) 89
science & technology (89) 89
cisplatin-based chemotherapy (88) 88
oncology (71) 71
female (57) 57
chemotherapy (56) 56
male (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
cisplatin - administration & dosage (49) 49
middle aged (46) 46
adult (44) 44
aged (39) 39
cancer (31) 31
biological and medical sciences (30) 30
medical sciences (30) 30
neoplasm staging (25) 25
prognosis (24) 24
treatment outcome (24) 24
cisplatin - therapeutic use (23) 23
lung neoplasms - drug therapy (23) 23
antineoplastic agents (21) 21
cisplatin - adverse effects (21) 21
tumors (21) 21
retrospective studies (20) 20
carcinoma, non-small-cell lung - drug therapy (19) 19
pharmacology. drug treatments (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
cisplatin (16) 16
fluorouracil - administration & dosage (16) 16
cisplatin‐based chemotherapy (15) 15
antineoplastic agents - therapeutic use (14) 14
survival rate (14) 14
combined modality therapy (13) 13
medicine & public health (13) 13
non-small cell lung cancer (13) 13
survival analysis (13) 13
chemotherapy, adjuvant (12) 12
quality of life (12) 12
radiotherapy (12) 12
risk factors (11) 11
survival (11) 11
toxicity (11) 11
adolescent (10) 10
analysis (10) 10
antineoplastic agents - adverse effects (10) 10
care and treatment (10) 10
testicular cancer (10) 10
antimitotic agents (9) 9
carcinoma, squamous cell - pathology (9) 9
obstetrics & gynecology (9) 9
ovarian cancer (9) 9
research (9) 9
adenocarcinoma - drug therapy (8) 8
adenocarcinoma - pathology (8) 8
carcinoma, non-small-cell lung - mortality (8) 8
carcinoma, non-small-cell lung - pathology (8) 8
carcinoma, squamous cell - drug therapy (8) 8
follow-up studies (8) 8
hematology, oncology and palliative medicine (8) 8
lung cancer (8) 8
lung neoplasms - mortality (8) 8
lung neoplasms - pathology (8) 8
metastasis (8) 8
patients (8) 8
pharmacology & pharmacy (8) 8
umcg approved (8) 8
cisplatin based chemotherapy (7) 7
disease-free survival (7) 7
etoposide - administration & dosage (7) 7
gynecology. andrology. obstetrics (7) 7
home care services, hospital-based (7) 7
internal medicine (7) 7
ovarian neoplasms - drug therapy (7) 7
ovarian neoplasms - pathology (7) 7
pathology (7) 7
testicular neoplasms - drug therapy (7) 7
vomiting - chemically induced (7) 7
aged, 80 and over (6) 6
antineoplastic agents - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
bladder cancer (6) 6
cancer therapies (6) 6
child (6) 6
deoxycytidine - administration & dosage (6) 6
deoxycytidine - analogs & derivatives (6) 6
drug administration schedule (6) 6
gemcitabine (6) 6
medical prognosis (6) 6
neoplasms - drug therapy (6) 6
prospective studies (6) 6
surgery (6) 6
testicular neoplasms - therapy (6) 6
time factors (6) 6
urology & nephrology (6) 6
adjuvant chemotherapy (5) 5
bleomycin - administration & dosage (5) 5
cancer research (5) 5
carcinoma (5) 5
carcinoma, squamous cell - mortality (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (134) 134
Japanese (13) 13
German (4) 4
Korean (2) 2
French (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Chemotherapy-induced peripheral neurotoxicity
by Cavaletti, Guido and Marmiroli, Paola
Nature reviews. Neurology, ISSN 1759-4758, 12/2010, Volume 6, Issue 12, pp. 657 - 666
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Peripheral Nervous System Diseases - therapy | Peripheral Nervous System Diseases - chemically induced | Antineoplastic Agents - adverse effects | Humans | Neoplasms - drug therapy | Drugs | Nervous system diseases | Chemotherapy | Diagnosis | Research | Health aspects | Risk factors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: A prospective, randomized, placebo-controlled phase 2 study
by Hiura, Yuichiro and Takiguchi, Shuji and Yamamoto, Kazuyoshi and Takahashi, Tsuyoshi and Kurokawa, Yukinori and Yamasaki, Makoto and Nakajima, Kiyokazu and Miyata, Hiroshi and Fujiwara, Yoshiyuki and Mori, Masaki and Kangawa, Kenji and Doki, Yuichiro
Cancer, ISSN 0008-543X, 10/2012, Volume 118, Issue 19, pp. 4785 - 4794
cisplatin-based chemotherapy | ghrelin | appetite | esophageal cancer | food intake | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Tumors | Esophagus | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Ghrelin - administration & dosage | Prospective Studies | Nausea - chemically induced | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Esophageal Neoplasms - pathology | Patient Selection | Adult | Female | Surveys and Questionnaires | Vomiting - prevention & control | Ghrelin - therapeutic use | Appetite - drug effects | Treatment Outcome | Energy Intake - drug effects | Carcinoma, Squamous Cell - physiopathology | Nausea - prevention & control | Vomiting - chemically induced | Carcinoma, Squamous Cell - drug therapy | Neoadjuvant Therapy - methods | Cisplatin - adverse effects | Esophageal Neoplasms - physiopathology | Quality of Life | Aged | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Chemotherapy | Usage | Care and treatment | Ghrelin | Research | Esophageal cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Thromboembolic events after high‐intensity training during cisplatin‐based chemotherapy for testicular cancer: Case reports and review of the literature
by Thorsen, Lene and Haugnes, Hege S and Fosså, Sophie D and Brydøy, Marianne and Tandstad, Torgrim and Wisløff, Torbjørn and Gjerset, Gunhild M and Edvardsen, Elisabeth and Larsen, Karl‐Otto and Sandset, Per Morten and Henriksson, Carola E and Raastad, Truls and Negaard, Helene F. S
International journal of cancer, ISSN 0020-7136, 12/2020, Volume 147, Issue 11, pp. 3189 - 3198
cisplatin‐based chemotherapy | testicular cancer | high‐intensity training | thromboembolic events | cisplatin-based chemotherapy | high-intensity training | Life Sciences & Biomedicine | Oncology | Science & Technology | Oncology, Experimental | Research | Metastasis | Antineoplastic agents | Testicular cancer | Antimitotic agents | Pulmonary embolism | Chemotherapy | Heart beat | Weight training | Exercise therapy | Thromboembolism | Cancer | Myocardial infarction | Physical training | Case reports | Cisplatin | Embolism | Metastases | Literature reviews | Heart rate | Physical fitness | Exercise | Cardiorespiratory fitness | Testes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
by Xu, He and Zeng, Liang and Guan, Yongjun and Feng, Xiangling and Zhu, Yinghong and Lu, Yichen and Shi, Chen and Chen, Shilian and Xia, Jiliang and Guo, Jiaojiao and Kuang, Chunmei and Li, Wei and Jin, Fengyan and Zhou, Wen
Journal of cellular biochemistry, ISSN 0730-2312, 03/2019, Volume 120, Issue 3, pp. 3547 - 3558
nasopharyngeal carcinoma (NPC) | NEK2 | cisplatin‐based chemotherapy resistance | cisplatin-based chemotherapy resistance | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Cell survival | Nek2 protein | Pathogenesis | Xenotransplantation | Ribonucleic acid--RNA | Survival | Cisplatin | Proteins | Nasopharyngeal carcinoma | Chemotherapy | Medical prognosis | Xenografts | Biomarkers | Index Medicus | s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients
by Hiura, Yuichiro and Takiguchi, Shuji and Yamamoto, Kazuyoshi and Takahashi, Tsuyoshi and Kurokawa, Yukinori and Yamasaki, Makoto and Nakajima, Kiyokazu and Miyata, Hiroshi and Fujiwara, Yoshiyuki and Mori, Masaki and Kangawa, Kenji and Doki, Yuichiro
Cancer, ISSN 0008-543X, 10/2012, Volume 118, Issue 19, pp. 4785 - 4794
cisplatin‐based chemotherapy | ghrelin | appetite | esophageal cancer | food intake | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Long‐term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin‐based chemotherapy for malignant ovarian germ cell tumor
by Solheim, Olesya and Skalleberg, Jacob and Warncke, Torhild and Ørstavik, Kristin and Tropé, Claes and Fosså, Sophie D
Acta obstetricia et gynecologica Scandinavica, ISSN 0001-6349, 02/2019, Volume 98, Issue 2, pp. 240 - 249
cisplatin‐based chemotherapy | peripheral paresthesia | neuropathy | Raynaud's phenomenon | malignant ovarian germ cell tumors | cisplatin-based chemotherapy | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Neurotoxicity | Chemotherapy | Side effects | Raynaud disease | Womens health | Ovarian cancer | Quantitative analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2‐T4aN0‐N2M0 bladder cancer
by Wosnitzer, Matthew S and Hruby, Gregory W and Murphy, Alana M and Barlow, Lamont J and Cordon‐Cardo, Carlos and Mansukhani, Mahesh and Petrylak, Daniel P and Benson, Mitchell C and McKiernan, James M
Cancer, ISSN 0008-543X, 01/2012, Volume 118, Issue 2, pp. 358 - 364
cisplatin‐based chemotherapy | neoadjuvant chemotherapy | adjuvant chemotherapy | systemic chemotherapy | muscle‐invasive bladder cancer | locally advanced bladder cancer | Neoadjuvant chemotherapy | Adjuvant chemotherapy | Muscle-invasive bladder cancer | Locally advanced bladder cancer | Cisplatin-based chemotherapy | Systemic chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Urinary Bladder Neoplasms - mortality | Humans | Middle Aged | Carboplatin - administration & dosage | Male | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Cisplatin - administration & dosage | Cystectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Aged | Retrospective Studies | Chemotherapy, Adjuvant | Neoadjuvant therapy | Care and treatment | Patient outcomes | Adjuvant treatment | Research | Bladder cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
by Susumu, Nobuyuki and Sagae, Satoru and Udagawa, Yasuhiro and Niwa, Kenji and Kuramoto, Hiroyuki and Satoh, Shinji and Kudo, Ryuichi and Japanese Gynecologic Oncology Group
Gynecologic oncology, ISSN 0090-8258, 2007, Volume 108, Issue 1, pp. 226 - 233
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Adjuvant radiotherapy | Adjuvant chemotherapy | Endometrial cancer | Cisplatin-based chemotherapy | Intermediate risk | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Endometrial Neoplasms - radiotherapy | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Adenocarcinoma - radiotherapy | Doxorubicin - administration & dosage | Risk Factors | Treatment Outcome | Adenocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - surgery | Cisplatin - adverse effects | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Patient Compliance | Neoplasm Staging | Doxorubicin - adverse effects | Adenocarcinoma - surgery | Care and treatment | Chemotherapy | Oncology, Experimental | Clinical trials | Research | Radiotherapy | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer
by Woodard, Gavitt A and Wang, Sue X and Kratz, Johannes R and Zoon-Besselink, Clara T and Chiang, Chun-Yuan and Gubens, Matthew A and Jahan, Thierry M and Blakely, Collin M and Jones, Kirk D and Mann, Michael J and Jablons, David M
Clinical lung cancer, ISSN 1525-7304, 2017, Volume 19, Issue 1, pp. 58 - 64
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | NCCN guidelines | Tumor genetic profile | Prognostic genetic signature | Cisplatin-based adjuvant therapy | Risk stratification | NCCN guidelines | Tumor genetic profile | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Predictive Value of Tests | Prognosis | Carcinoma, Non-Small-Cell Lung - genetics | Lung Neoplasms - mortality | Humans | Male | Risk | Carcinoma, Non-Small-Cell Lung - mortality | Drug Resistance, Neoplasm - genetics | Survival Analysis | Pathology, Molecular - methods | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Chemotherapy, Adjuvant | Neoplasm Staging | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights